By 2024, Yescarta, a Car-T therapy from Gilead Sciences, is expected to have the largest revenue in both regions with 966 million U.S. dollars in the United States and 321 million U.S. dollars in Europe. This statistic shows the estimated 2024 revenues for selected anti-CD19 Car-T therapy in the U.S. and in Europe.
Estimated 2024 revenues of selected anti-CD19 Car-T therapies in the U.S. and in Europe
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Evaluate. (January 21, 2020). Estimated 2024 revenues of selected anti-CD19 Car-T therapies in the U.S. and in Europe (in million U.S. dollars) [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/1092905/car-t-therapy-revenue-forecast-us-europe/
Evaluate. "Estimated 2024 revenues of selected anti-CD19 Car-T therapies in the U.S. and in Europe (in million U.S. dollars)." Chart. January 21, 2020. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/1092905/car-t-therapy-revenue-forecast-us-europe/
Evaluate. (2020). Estimated 2024 revenues of selected anti-CD19 Car-T therapies in the U.S. and in Europe (in million U.S. dollars). Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/1092905/car-t-therapy-revenue-forecast-us-europe/
Evaluate. "Estimated 2024 Revenues of Selected Anti-cd19 Car-t Therapies in The U.S. and in Europe (in Million U.S. Dollars)." Statista, Statista Inc., 21 Jan 2020, https://www.statista.com/statistics/1092905/car-t-therapy-revenue-forecast-us-europe/
Evaluate, Estimated 2024 revenues of selected anti-CD19 Car-T therapies in the U.S. and in Europe (in million U.S. dollars) Statista, https://www.statista.com/statistics/1092905/car-t-therapy-revenue-forecast-us-europe/ (last visited December 22, 2024)
Estimated 2024 revenues of selected anti-CD19 Car-T therapies in the U.S. and in Europe (in million U.S. dollars) [Graph], Evaluate, January 21, 2020. [Online]. Available: https://www.statista.com/statistics/1092905/car-t-therapy-revenue-forecast-us-europe/
